Honestly heard of this for the first time! Very difficult diagnosis! No treatment implications yet I hope !!!

This is very helpful; at the same very scary !!! #SH23

Eosinophilic Variant of Marginal zone lymphoma, with overlapping features of AITL. Excellent post !!! Very difficult diagnosis too! Siba El Hussein, MD

Everyone is talking about MRD at #ASH23 You need to make sure your sample is not hemodiluted We now have a way of measuring hemodilution using flow cytometry, publication from iStopMM here: nature.com/articles/s4140… Calculator: istopmm.com/bmqi/ Jón Þórir Óskarsson Blood Cancer Journal

The thing with molecular pathology is that, it should be updated timely and kudos to the authors who have done it, along with the updated WHO classifications. Very helpful to both path and medicine Residents and Fellows. Checking my book fund now!!!

Merry Christmas from my family to yours!!!

#hemepath. Key features of this disease - follicular hyperplasia, eosinophilia, polykaryocytes. Also, I forgot I knew this - increased IgG4! Kimura disease

Out today 🚨all you need to know about B cell lymphoma Dx in one beautiful paper ⁦LJMedeirosMD⁩ ⁦Yaso Natkunam⁩ #hemepath ⁦Modern Pathology⁩ #lymsm modernpathology.org/article/S0893-…

🩸Indolent T lymphoblastic proliferation (IT-LBP) is an extra-thymic non-clonal expansion of T-lymphoblasts 🩸It occurrs alone or in association with other disorders, including Castleman disease (as illustrated in below Figures 1-3) and others (myasthenia gravis, hepatocellular

An article in Annals of Diagnostic Pathology journal on Monomorphic Epitheliotropic intestinal T cell lymphoma (MEITL) with an unusual immunophenotype and discussion of differential diagnosis. Thank you LJMedeirosMD at MD Anderson for this opportunity. doi.org/10.1016/j.annd…

It’s great when your own institute appreciates your research and provides you with a platform to display it. BCM_PathRes BCMHouston keeps showing us it keeps education above everything else!!! Pathology Research Symposium.

⬅️Osteoblasts (benign) vs ➡️myeloid blasts (leukemia) Same environment 🦴 different genes 🧬 The osteoblasts seem much more friendly and social!

If I had a nickel for every time a woman named Rosalind got neither the credit nor a Nobel Prize for her work, I'd have two nickels, which isn't a lot, but it's weird that it happened twice.

TFH lymphoma enthusiasts; Dense paper but a must read for all hemepath folk. Never thought I would write the future directions section for a lymphoma review paper in a such a renowned journal. All your comments and feedback are welcome. #hemepath #hematopathology #lymphoma

#CAP2024 CAPathologists BCM_PathRes Always proud to represent my program at the national program! 😎

Ahead of print in AJSP! Very helpful article that provides directions as to which B cell proliferations in TFH lymphomas should be considered a part of the TFH process and which ones “bonafide” lymphomas. #hemepath #pathtwitter #lymphoma DOI: 10.1097/PAS.0000000000002340

The next time you get a pancytopenic patient with history of Anti-epileptic treatment, Call, not only the heme-onc for bone marrow failure work-up but also the rheumatologist for lupus work-up. An important case report. doi.org/10.1097/MPH.00… #hemepath #lupus

Got the “Speaker” badge for the first time at the annual HSCP Gallager event representing Baylor College of Medicine. Thank you Houston Society of Clinical Pathology for the opportunity to present my research on DICER1 sarcomas. Hou Soc of Clin Path BCM_PathRes

Congratulations to us ! 🙂